Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Glaukos Corporation Common Stock
(NY:
GKOS
)
166.27
+3.10 (+1.90%)
Delayed Quote
Updated: 10:15 AM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Glaukos Corporation Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
FDA Approves Glaukos' Eye Implant To Treat Eye Pressure In Glaucoma Patients
↗
December 14, 2023
The FDA approved Glaukos Corporation's (NYSE: GKOS) marketing application for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog indicated for...
Via
Benzinga
Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
December 14, 2023
From
Glaukos Corporation
Via
Business Wire
Analyst Ratings for Glaukos
↗
November 28, 2023
Via
Benzinga
4 Analysts Have This to Say About Glaukos
↗
November 08, 2023
Via
Benzinga
Glaukos Announces Participation in Stifel Healthcare Conference
November 07, 2023
From
Glaukos Corporation
Via
Business Wire
8 Analysts Have This to Say About Glaukos
↗
September 26, 2023
Via
Benzinga
Glaukos's Earnings Outlook
↗
August 01, 2023
Via
Benzinga
Analyst Ratings for Glaukos
↗
July 31, 2023
Via
Benzinga
Where Glaukos Stands With Analysts
↗
July 14, 2023
Via
Benzinga
Glaukos Announces Third Quarter 2023 Financial Results
November 01, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
October 31, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
October 11, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Participation in Wells Fargo Healthcare Conference
August 23, 2023
From
Glaukos Corporation
Via
Business Wire
Stifel Maintains Buy Rating for Glaukos: Here's What You Need To Know
↗
June 26, 2023
Via
Benzinga
8 Analysts Have This to Say About Glaukos
↗
June 26, 2023
Via
Benzinga
Analyst Expectations for Glaukos's Future
↗
June 05, 2023
Via
Benzinga
Glaukos Announces Second Quarter 2023 Financial Results
August 02, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Poised To Surpass Expectations And Raise Outlook In Q2 FY23, Fueled By iStent And iAccess Launches: Analyst
↗
July 19, 2023
Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside...
Via
Benzinga
Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
July 17, 2023
From
Glaukos Corporation
Via
Business Wire
These 2 Soaring Stocks Finished the Week Strong
↗
July 14, 2023
Wall Street coasted into the close on Friday but still had a good week.
Via
The Motley Fool
Glaukos: Q1 Earnings Insights
↗
May 03, 2023
Via
Benzinga
UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday
↗
July 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
July 12, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Poised for $1B in Sales by 2030: Piper Sandler Predicts With Stock Upgrade
↗
June 07, 2023
Piper Sandler has upgraded Glaukos Corporation (NYSE: GKOS) to Overweight from a Neutral ra
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023
↗
June 07, 2023
Via
Benzinga
Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
June 05, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Participation in the William Blair Growth Stock Conference
May 24, 2023
From
Glaukos Corporation
Via
Business Wire
Tyson Foods, PayPal And 3 Stocks To Watch Heading Into Monday
↗
May 08, 2023
With US stock futures trading slightly lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Glaukos Announces FDA Acceptance of NDA Submission for iDose TR
May 05, 2023
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces First Quarter 2023 Financial Results
May 03, 2023
From
Glaukos Corporation
Via
Business Wire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
